Nanoparticles Modified with Cell-Penetrating Peptides: Conjugation Mechanisms, Physicochemical Properties, and Application in Cancer Diagnosis and Therapy
Open accessThe DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index.
Abstract
Based on their tunable physicochemical properties and the possibility of producing cell-specific platforms through surface modification with functional biomolecules, nanoparticles (NPs) represent highly promising tools for biomedical applications. To improve their potential under physiological conditions and to enhance their cellular uptake, combinations with cell-penetrating peptides (CPPs) represent a valuable strategy. CPPs are often cationic peptide sequences that are able to translocate across biological membranes and to carry attached cargos inside cells and have thus been recognized as versatile tools for drug delivery. Nevertheless, the conjugation of CPP to NP surfaces is dependent on many properties from both individual components, and further insight into this complex interplay is needed to allow for the fabrication of highly stable but functional vectors. Since CPPs per se are nonselective and enter nearly all cells likewise, additional decoration of NPs with homing devices, such as tumor-homing peptides, enables the design of multifunctional platforms for the targeted delivery of chemotherapeutic drugs. In this review, we have updated the recent advances in the field of CPP-NPs, focusing on synthesis strategies, elucidating the influence of different physicochemical properties, as well as their application in cancer research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873 · cited 2×
“In fact, their fate is highly influenced by their physicochemical properties, such as particle size and surface modification, that determine the biodistribution, blood circulation time, protein corona formation, toxicity, and immunological response [52].”
BackgroundDoxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · cited 1×
“The tunable physicochemical properties, which rely mainly on the choice of lipid and the preparation method, along with their high biocompatibility has led to the first FDA approved nano-drug in 1995, Doxil®, doxorubicin-loaded liposome [34].”
BackgroundAtomically Precise Colloidal Metal Nanoclusters and Nanoparticles: Fundamentals and Opportunities
Jin, R., Zeng, C., Zhou, M., & Chen, Y. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00703 · Cited by 3,459 · cited 1×
“The occurrence of size- and shape-dependent surface plasmon resonance (SPR) has led to the fabrication of gold NPs in various sizes and shapes, including rod-shaped, star-shaped, and nanoshells [41].”
BackgroundNear-infrared fluorophores for biomedical imaging
Hong, G., Antaris, A. L., & Dai, H. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-016-0010 · Cited by 2,985 · cited 1×
“Other near infrared-emitting structures, such as carbon nanotubes or lanthanide-doped NPs, are likewise useful for bioimaging and PTT applications; however, their potential toxicity has so far limited their employment in clinical trials [43].”
BackgroundCellular uptake of the tat protein from human immunodeficiency virus
Frankel, A. D., & Pabo, C. O. (1988) · Cell · doi:10.1016/0092-8674(88)90263-2 · Cited by 2,783 · cited 2×
“Tat (48–60) GRKKRRQRRRPPQ [5,6] Penetratin RQIKIWFQNRRMKWKK [14] VP22 RPRAPARSASRPRRPVE [13] R9 RRRRRRRRR [10] sC18 GLRKRLRKFRNKIKEK [12] MAP KLALKLALKALKAALKLA [15] Pept1 PLILLRLLRGQF [16]”
BackgroundThe third helix of the Antennapedia homeodomain translocates through biological membranes.
Derossi, D., Joliot, A. H., Chassaing, G., & Prochiantz, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34080-2 · Cited by 2,034
Nanotechnology for Multimodal Synergistic Cancer Therapy
Fan, W., Yung, B., Huang, P., & Chen, X. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,791 · cited 1×
“The controlled killing of diseased cells is commonly performed through the application of heat (photothermal therapy, hyperthermia), ultrasound, radiation, activation of reactive oxygen species (photodynamic therapy), gene and immune-modulation, the delivery of high payloads of drug molecules, or combinations thereof…”
BackgroundFutaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., & Sugiura, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007540200 · Cited by 1,662 · cited 2×
“Tat (48–60) GRKKRRQRRRPPQ [5,6] Penetratin RQIKIWFQNRRMKWKK [14] VP22 RPRAPARSASRPRRPVE [13] R9 RRRRRRRRR [10] sC18 GLRKRLRKFRNKIKEK [12] MAP KLALKLALKALKAALKLA [15] Pept1 PLILLRLLRGQF [16]”
BackgroundEndosomal escape pathways for delivery of biologicals
Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.004 · Cited by 1,561 · cited 1×
“Following this mediates endosomal swelling and disruption with the final release of the entrapped cargo [20].”
BackgroundGreen, M., & Loewenstein, P. M. (1988) · Cell · doi:10.1016/0092-8674(88)90262-0 · Cited by 1,553 · cited 2×
“Tat (48–60) GRKKRRQRRRPPQ [5,6] Penetratin RQIKIWFQNRRMKWKK [14] VP22 RPRAPARSASRPRRPVE [13] R9 RRRRRRRRR [10] sC18 GLRKRLRKFRNKIKEK [12] MAP KLALKLALKALKAALKLA [15] Pept1 PLILLRLLRGQF [16]”
Background
Cited by
Items 101–200 of 213
Marecki, E. K., Oh, K. W., Knight, P. R., & Davidson, B. A. (2024) · Biomicrofluidics · doi:10.1063/5.0201465 · Cited by 17
Cell-Penetrating Peptides in infection and immunization
Du, Y., Xiong, Y., Sha, Z., Guo, D., Fu, B., Lin, X., & Wu, H. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127963 · Cited by 15
Cui, N., Fan, T., Li, L., Liu, W., Li, M., Huang, M., Wu, Q., Wang, J., Zhang, W., Wang, S., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.160664 · Cited by 15
Filho, O. P. D. S., Ali, M., Nabbefeld, R., Primavessy, D., Bovée‐Geurts, P. H. M., Grimm, S., Kirchner, A., Wiesmüller, K., Schneider, M., Walboomers, X. F., et al. (2021) · RSC Advances · doi:10.1039/d1ra05871a · Cited by 14
Gold nanomaterials and their potential use as cryo-electron tomography labels
Beales, C. T., & Medalia, O. (2022) · Journal of Structural Biology · doi:10.1016/j.jsb.2022.107880 · Cited by 14
Sharma, M., Panwar, D., Tiwari, P., Kumar, A., Gautam, S., Marwaha, D., Rai, N., Singh, N., Bakshi, A. K., Agarwal, N., et al. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213672 · Cited by 15
Nagaraj, H., Lehot, V., Nasim, N., Çiçek, Y. A., Goswami, R., Jeon, T., & Rotello, V. M. (2025) · RSC Pharmaceutics · doi:10.1039/d5pm00129c · Cited by 13
Devi, N., Singh, P., Sharma, R. K., Kumar, M., Pandey, S. K., Sharma, R. K., & Wangoo, N. (2022) · Journal of Materials Science · doi:10.1007/s10853-022-07681-z · Cited by 12
Manchanda, N., Vishkarma, H., Goyal, M., Shah, S., Famta, P., Talegaonkar, S., & Srivastava, S. (2024) · Current Drug Targets · doi:10.2174/0113894501285598240216065627 · Cited by 12
Giang, N. N., Kim, S. G., In, I., & Park, S. Y. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c01778 · Cited by 11
Lv, W., & Champion, J. A. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102315 · Cited by 12
Blal, N., Bardi, G., Pompa, P. P., & Guarnieri, D. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202408436 · Cited by 12
Functionalizing Thiosemicarbazones for Covalent Conjugation
Hohnsen, J., Rryci, L., Obretenova, D., Friedel, J., Jouchaghani, S., & Klein, A. (2024) · Molecules · doi:10.3390/molecules29153680 · Cited by 10
“This might explain in part the poor yields (43 to 77%).”
BackgroundBiomedical applications of peptide-gold nanoarchitectonics
Maghsoudian, S., Sajjadi, E., Hadavi, N., Soltani, M., Karami, Z., Al-Qushawi, A. A. H., Akrami, M., & Kalantari, F. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124920 · Cited by 11
Phatale, V., Khairnar, P., Shukla, S., Puri, N., Sahane, P., & Srivastava, S. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126077 · Cited by 11
Dong-ying, Q., Lan, L., & Ding, Q. (2020) · Process Biochemistry · doi:10.1016/j.procbio.2020.07.019 · Cited by 10
Varró, N., Mándityné Huszka, B., Erdei, E., Mándoki, A., & Mándity, I. M. (2025) · Chemistry–Methods · doi:10.1002/cmtd.202500010 · Cited by 8
Electrostatic Gelatin Nanoparticles for Biotherapeutic Delivery
Tobo, C., Jain, A., Gamage, M. E., Jelliss, P. A., & Garg, K. (2024) · Gels · doi:10.3390/gels10120757 · Cited by 10
Jang, Y. E., Kwon, M., Kim, S. G., George, N. P., Hwang, J. S., Basith, S., & Lee, G. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.110590 · Cited by 8
Skepu, A., Phakathi, B., Makgoka, M., Mbita, Z., Damane, B. P., Demetriou, D., & Dlamini, Z. (2023) · Springer eBooks · doi:10.1007/978-3-031-21506-3_9 · Cited by 8
Vijayan, A. N., Indrakumar, J., Gomathinayagam, S., Muthukaliannan, G. K., & Korrapati, P. S. (2022) · Macromolecular Research · doi:10.1007/s13233-022-0061-5 · Cited by 8
Kulkarni, T., Mukhopadhyay, D., & Bhattacharya, S. (2021) · SSRN Electronic Journal · doi:10.1016/j.apsusc.2022.153175 · Cited by 8
Recent advances of physiochemical cues on surfaces for directing cell fates
Deng, W., Yang, X., Yu, J., Omari‐Siaw, E., & Xu, X. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.114550 · Cited by 9
Role of charge in enhanced nuclear transport and retention of graphene quantum dots
Gorav, G., Khedekar, V., Varier, G. K., & Nandakumar, P. (2024) · Scientific Reports · doi:10.1038/s41598-024-69809-2 · Cited by 7
“Quantum dots or nanoparticles can be used as a probe in different microscopic techniques such as two-photon microscopy, confocal microscopy, and fluorescence resonance energy transfer microscopy [32, 33, 29, 31, 34].”
BackgroundDesigned Cell-Penetrating Peptide Constructs for Inhibition of Pathogenic Protein Self-Assembly
Kalmouni, M., Oh, Y., Alata, W., & Magzoub, M. M. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16111443 · Cited by 7
Tomono, T., Yagi, H., Kanemoto, S., Ukawa, M., Miyata, K., Shigeno, K., & Sakuma, S. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121519 · Cited by 7
Maeng, J., & Lee, K. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2122636 · Cited by 7
“The guanidine head group of Arg in PTD was reported to take part in the hydrogen bonding between the lipid bilayer and Arg of peptide (Goun et al., 2006).”
BackgroundRathnam, S. S., Deepak, T., Sahoo, B. N., Meena, T., Singh, Y., & Joshi, A. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001689 · Cited by 7
A novel navigated doxorubicin delivery formulation to breast cancer therapy
Cheng, S., Lu, Z., Feng, Y., Zhao, X., Zhao, R., Qiu, Z., Jia, C., Chen, L., Yuan, Y., Li, X., et al. (2022) · Materials Today Advances · doi:10.1016/j.mtadv.2022.100235 · Cited by 8
Unravelling drug delivery using in vitro Fluorescence Correlation Spectroscopy (FCS)
van den Hoven, L., Goddaer, S., Mirzahossein, E., Vermonden, T., Koynov, K., Remaut, K., & van Ravensteijn, B. G. P. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114311 · Cited by 6
Methods To Enhance The Metabolic Stability Of Peptide Drugs
Ivanova, S., Mihaylova, S. G., & Tsvetkova, A. (2021) · Varna Medical Forum · doi:10.14748/vmf.v10i2.7935 · Cited by 6
Santino, F., Stavole, P., He, T., Pieraccini, S., Paolillo, M., Prodi, L., Rampazzo, E., & Gentilucci, L. (2022) · Micro · doi:10.3390/micro2020016 · Cited by 6
“These reactions proceed with variable degrees of efficiency [4,26], giving more or less homogenous peptide coatings.”
BackgroundWaithera, M. W., Sifuna, M. W., Kariuki, D. W., Kinyua, J. K., Kimani, F. T., Nganga, J. K., & Takei, M. (2023) · Parasitology Research · doi:10.1007/s00436-023-07801-x · Cited by 6
“Since the intestinal membrane acts as the first barrier to orally administered large and charged molecules (Gessner and Neundorf 2020), poor performance and low drug concentrations at target regions is attributed to limited solubility in aqueous media (Mehmood et al.”
BackgroundInorganic gold nanoparticles-TAT hybrid for the effective delivery of doxorubicin into cancer cells
Bansal, K., Devi, N., Aqdas, M., Kumar, M., Agrewala, J. N., Katare, O. P., Sharma, R. K., & Wangoo, N. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104959 · Cited by 9
Rano, S., Bhaduri, A., & Singh, M. (2023) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2023.106876 · Cited by 8
Salgado, L., Cifuentes-Delgado, P. C., Orozco, J. C., Muñoz-Camargo, C., Reyes, L. H., Quezada, V., & Cruz, J. C. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1450694 · Cited by 5
Matsuda, M., Ikeda, K., Kameda, T., Nakao, H., & Nakano, M. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00628 · Cited by 5
Dubey, A., Bisht, A., Vikal, A., Patel, P., & Kurmi, B. D. (2024) · International Journal of Newgen Research in Pharmacy & Healthcare · doi:10.61554/ijnrph.v2i1.2024.75 · Cited by 7
“[46] Mucosal Barriers Nanoparticles can be engineered with surface modifications that allow them to bypass mucus entrapment, facilitating penetration through mucosal barriers.”
BackgroundManoswini, M., Majumdar, A. G., Pany, B., Sahu, B. R., & Mohanty, P. S. (2023) · Emergent Materials · doi:10.1007/s42247-022-00441-4 · Cited by 5
“A few disadvantages of using the non-covalent conjugation method are the need for a high concentration of antibodies for the preparation of antibody–NP conjugates, the biological response being difficult to control due to electrostatic attraction between the conjugates, random orientation of antibodies on the nanopart…”
BackgroundLützenburg, T., Burdina, N., Scholz, M., & Neundorf, I. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122075 · Cited by 6
Self-citationRecent Updates on Peptide Molecules in Drug and Vaccine Development
Sarfaraz, M., Anjum, F., Zahra, D., Maqsood, A., & Ashfaq, U. A. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230717121632 · Cited by 7
Nanomedicine targeting the Warburg effect: Advanced strategies for cancer therapy
Wang, X., Yang, W., Shen, B., Jiang, B., Zhang, Z., & Wu, H. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104922 · Cited by 5
Surface-modified organic nanoparticles for lung cancer targeted therapy
Gündel, S. D. S., Alves, A. D. C. S., Dallemole, D. R., Guterres, S. S., & Pohlmann, A. R. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.115175 · Cited by 6
Menazea, A. A., Assaggaf, H. M., Alghamdi, S. A., Eldrehmy, E. H., Elabbasy, M. T., & El-Kader, M. F. H. A. (2021) · Journal of Materials Science Materials in Electronics · doi:10.1007/s10854-021-07372-6 · Cited by 4
Do Messenger RNA Vaccines Induce Pathological Syncytia?
Sfera, A., Thomas, K. G., Sfera, D. O., Anton, J. J., Andronescu, C. V., Jafri, N., Sasannia, S., & Kozlakidis, Z. (2022) · International Journal of Pathology and Clinical Research · doi:10.23937/2469-5807/1510137 · Cited by 5
Pajerski, W., Chytrosz-Wróbel, P., Gołda‐Cępa, M., Pawlyta, M., Reczyński, W., Ochońska, D., Brzychczy‐Włoch, M., & Kotarba, A. (2022) · New Journal of Chemistry · doi:10.1039/d2nj00648k · Cited by 4
Advancement and application of novel cell-penetrating peptide in cancer management
Yadav, S., & Singh, P. (2023) · 3 Biotech · doi:10.1007/s13205-023-03649-1 · Cited by 4
“The anticancer drug doxorubicin (DOX) is transported using -helix peptide 17-amino acids combined with gold nanoparticles as vectors; this approach has been used to deliver more efficiently than free DOX for cellulite-selective internalization activities of the chosen peptides.”
BackgroundInfluentialLoushambam, B., Krishnaswami, V., Kumar, M., & Vijayaraghavalu, S. (2026) · Journal of Pharmaceutical and BioTech Industry · doi:10.3390/jpbi3010005 · Cited by 3
Bauri, S., Yadav, P. K., Choudhury, A. M., & Maiti, P. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c01479 · Cited by 3
Conditional Cell Penetration of Masked CPPs by an ADEPT-like Approach
Hofmann, S., Dombrowsky, C. S., Happel, D., Dessin, C., Cermjani, E., Cica, M., Avrutina, O., Sewald, N., Neumann, H., & Kolmar, H. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00149 · Cited by 3
González, R., & Carvalho, A. T. P. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.4c02294 · Cited by 3
Toxicity, Legal and Health Aspects of Nanomaterials
Mishra, S., Sharma, V., & Gupta, R. (2022) · Springer eBooks · doi:10.1007/978-3-030-69023-6_104-1 · Cited by 3
Gessner, I., Klimpel, A., & Neundorf, I. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1752-6_7 · Cited by 3
Self-citationRiding the wave of innovation: nanotechnology in nucleic acid-based cancer therapy
Kavita, K., Singh, B., & Sharma, T. (2025) · 3 Biotech · doi:10.1007/s13205-025-04397-0 · Cited by 2
“…and intracellular delivery of NPs, ensuring efficient release (Wang et al. 2020) and action of the payloads while cell-penetrating peptides (CPPs) and tumor-homing peptides allow for the creation of multifunctional platforms tailored for specific biomedical applications (Gessner and Neundorf 2020).”
Cui, Z., Ma, J., Zhang, Y., Song, Z., & Xu, X. (2026) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2026.107415 · Cited by 4
Metal-Coordinated His-Tag Functionalization of Polymeric Nanogels for Therapeutic Applications
Colli, C., Filippis, A. D., Galbo, G., Kunkl, M., Ivanova, J. R., Fornoni, S., Spatz, J. P., Rosanò, L., Moscatelli, D., Tuosto, L., et al. (2026) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c05531 · Cited by 5
Exploring Peptido‐Nanocomposites in the Context of Amyloid Diseases
Andrikopoulos, N., Tang, H., Wang, Y., Liang, X., Li, Y., Davis, T. P., & Ke, P. C. (2023) · Angewandte Chemie · doi:10.1002/ange.202309958 · Cited by 2
Dayani, L., Hashempour, H., Varshosaz, J., Aliomrani, M., Dinani, M. S., & Taheri, A. (2023) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2023.121217 · Cited by 2
Development a novel drug delivery formulation targeting to esophageal squamous cell carcinoma
Feng, Y., Ge, J., Zhang, D., Bai, X., Fang, H., Zhou, Y., Che, W., Zhang, W., Zhao, R., Qiu, Z., et al. (2023) · Materials Today Advances · doi:10.1016/j.mtadv.2023.100407 · Cited by 2
Halbi, G., Fayer, I., Aranovich, D., Gat, S., Pavan, M. J., Nachmias, D., Sanchez, D. S., Brik, A., Granek, R., & Bernheim‐Groswasser, A. (2023) · The European Physical Journal E · doi:10.1140/epje/s10189-023-00331-5 · Cited by 3
Rahdari, M., Hashemi, H., Hashemi, S. M. A., Nadjafi-Semnani, A., Jamalie, S., Sakhaee, M. H., Zabihi, F., Razavi, S. A. S., Khaboushan, M. T., & Ahmadi, G. (2023) · Journal of Lab Animal Research · doi:10.58803/jlar.v2i5.31 · Cited by 3
Xu, P., Zhong, S., Ma, Y., Duan, X., Wei, Y., Zhang, M., Xu, J., & Zhang, Y. (2024) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c05423 · Cited by 2
Stimuli-Responsive PEGylated Nanocarriers
Almurisi, S. H., Rao, P. S. N., & Madheswaran, T. (2025) · Springer eBooks · doi:10.1007/978-981-97-7316-9_15 · Cited by 2
González, R., Simões, S. M. N., Ferreira, L., & Carvalho, A. T. P. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00444 · Cited by 2
CPP Functionalized Nanoparticles
Langel, Ü. (2023) · Springer eBooks · doi:10.1007/978-3-031-38731-9_17 · Cited by 1
Lawal, O., Niihori, M., James, J., Hinkle, A. J., Sano, T., McClain, N., Rafikov, R., & Rafikova, O. (2025) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2024-0296oc · Cited by 3
Functional immunopeptides: advancing prevention and therapeutic strategies against animal diseases
Pratama, A. C., Yin, X., Xu, J., & He, F. (2025) · Animal Diseases · doi:10.1186/s44149-025-00168-9 · Cited by 1
“These improvements are confirmed by significant increases in CD8 + T-cell responses following immunization with antigens conjugated to CPPs (Backlund et al. 2022; Gessner & Neundorf 2020).”
Coats, J. P., Nikoletić, A., Heuberger, L., Mihali, V., Schoenenberger, C., Dinu, I. A., & Palivan, C. G. (2025) · Macromolecular Rapid Communications · doi:10.1002/marc.202500418 · Cited by 1
Yamada, S., Sasaki, E., Ohno, H., Nagase, K., & Hanaoka, K. (2025) · Communications Chemistry · doi:10.1038/s42004-025-01707-8 · Cited by 1
Babel, A., Yuan, J., Saleh, N. A., Al‐Hilfi, A., Kilangodi, S., Sun, J., Asgedom, L., Withrow, A., Gilad, A. A., & Kanada, M. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c00582 · Cited by 1
Artificial intelligence in drug delivery system development
Ayyoubzadeh, S. M., Alizadeh, B., Davarikia, K., Heydari, S., & Ahmadi, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95464-8.00004-9 · Cited by 1
Nanotherapeutics for Multidrug Resistance Using Nanobiomaterial
Kumar, R. (2026) · Nanotechnology in the life sciences · doi:10.1007/978-3-032-08576-4_3 · Cited by 1
Functionalized Coiled-Coil Peptide Nanocrystals for Cellular Protein Delivery
Encinas, A., Agrahari, A., & Chmielewski, J. A. (2026) · Chemistry of Materials · doi:10.1021/acs.chemmater.5c03322 · Cited by 1
Self‐Assembling Hybrid Hydrogel Reprograms the Stromal Vascular Fraction to Treat Osteoarthritis
Hou, W., Chen, Y., Xiao, L., Qi, W., Du, T., Sun, Q., Xue, B., Zhao, Q., Xie, P., Ye, Z., et al. (2026) · Advanced Science · doi:10.1002/advs.202517297 · Cited by 1
“Conversely, covalent immobilization offers superior benefits through enhanced peptide stability and accurate spatial patterning, making it ideal for sustained stem-cell niche maintenance in applications such as cartilage regeneration [ 56, 57 ].”
Malek-Khatabi, A., Rahimzadegan, M., Razavi, M. S., Shabankareh, A. N. T., Sefat, F., & Nosrati, R. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119631 · Cited by 1
Bhaskar, R., Pandey, S. P., Sinha, J. K., & Han, S. S. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108689 · Cited by 1
Surface Chemistry-Based Nanomedicine Design in Oral Drug Delivery
Hu, J., Zhou, M., Lu, L., & Wang, J. (2026) · Polymer science & technology. · doi:10.1021/polymscitech.6c00042 · Cited by 1
Decoding the uptake pathway of nanoparticles in tumor cells: mechanisms, developments and challenges
Chen, Z., Zhou, L., Li, S., & Zhang, X. (2026) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2026.104054 · Cited by 1
Effective cell penetration of negatively‐charged proline‐rich SAP(E) peptides with cysteine mutation
Lim, S., Park, J., Chong, S., Kim, S., Choi, Y., Nam, S. H., & Lee, Y. (2022) · Peptide Science · doi:10.1002/pep2.24301 · Cited by 1
Magnetic Nanomaterials for Heavy Metals Detection
Emeji, I. C., Okoye-Chine, C. G., García-Rodríguez, O., Igberase, E., & Osifo, P. O. (2023) · Engineering materials · doi:10.1007/978-3-031-36088-6_4 · Cited by 1
Zhang, J., Cui, M., Tao, R., Yao, Y., Han, J., & Yu, S. (2023) · Coatings · doi:10.3390/coatings13081404 · Cited by 1
James, S. (2021) · Springer series in biomaterials science and engineering · doi:10.1007/978-981-33-6252-9_8
Research Advances of Homing Penetrating Peptide
苏, 畅. (2021) · Advances in Clinical Medicine · doi:10.12677/acm.2021.1111722
Nano Trojan Horses for Delivery of Peptides and Protein Drugs
Dharmatti, R. (2022) · Wiley eBooks · doi:10.1002/9781119764205.ch2
Science and Technology of Nanomaterials: Introduction
Thomas, M. S., Thomas, S., & Pothen, L. A. (2022) · Wiley eBooks · doi:10.1002/9783527834143.ch1
COVID-19 mRNA vaccines and pathological cell-cell fusion: an unintended consequence
Sfera, A., Thomas, K. G., Sfera, D. O., Anton, J. J., Andronescu, C. V., Jafri, N., Sasannia, S., & Kozlakidis, Z. (2022) · Archives of Clinical Trials · doi:10.33425/2768-4598.1019
Potential Approaches for Delivery of Surface Decorated Nano-carriers in the Management of Carcinoma
Patil, B. R., Tiwari, A., Pandey, S. P., Shukla, T., & Upmanyu, N. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815080506123010006
Toxicity, Legal, and Health Aspects of Nanomaterials
Mishra, S., Sharma, V., & Gupta, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-16101-8_104
Plastun, I. L., Zakharov, A. A., & Наумов, А. А. (2023) · Оптика и спектроскопия · doi:10.21883/os.2023.06.55904.117-23
Designer DNA Nanostructures and Their Cellular Uptake Behaviors
Ye, J., Yang, D., Shi, C., Zhou, F., & Wang, P. (2024) · Wiley eBooks · doi:10.1002/9783527840816.ch16 · Cited by 1
Yang, Y., Feng, B., Singh, A., Huang, J. C., Phan, P., Sastry, V., Zhao, Z., Du, W., Cheng, G., Malik, A. B., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5352047
Anticancer Therapy Against Glioma by Peptide-Based Therapeutics
Mitra, S., Das, S., Mukherjee, S., Karati, D., & Meur, S. (2025) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-025-10755-6
“Following the formation of coated pits by an adaptor protein binding to phosphatidylinositol 4,5-biphosphate, dynamin, second one explained the type, size, charge, and material composition of conjugated payload (Gessner and Neundorf 2020).”
Salahi, M., Varshosaz, J., Rostami, M. R., Esfahani, S. N., Hekmat, A., Jahanian‐Najafabadi, A., & Minayian, M. (2025) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2025.100457 · Cited by 1
“For instance, arginine residues can form bidentate hydrogen bonds with carboxyl, phosphate, and sulfate groups (Gessner and Neundorf, 2020).”
Nanomaterials in Therapeutic Application
Talukder, P., Nandi, A., Das, S., Sultana, S., & Sengupta, S. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898813123125010007
Feng, B., Singh, A., Yang, Y., Phan, P., Xu, H., Zhu, Y., Huang, J., Sastry, V., Zhao, Z., Hu, Y. S., et al. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.02.006 · Cited by 4
“…release, mannan was conjugated to a peptide sequence containing positively charged arginine (R) residues for nucleic acid binding and cell penetration [41 – 43], as well as histidine (H) residues, whose imidazole groups facilitate endo/lysosomal escape through a proton-sponge effect [44 – 46].”
Gandhi, M., & Ranga, S. (2026) · JOURNAL OF ADVANCE AND FUTURE RESEARCH · doi:10.56975/jaafr.v4i2.503300
Nanotechnology in follicle tracking and ovarian stimulation
Tiwari, G., Gadhave, R. V., Metri, S. M., Dev, D., Pawar, S. V., Rajendran, S. P., & Kela, P. R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-41561-6.00014-5
Nanocarriers modulating fibrinolytic pathways for the treatment of various neurological disorders
Mishra, K., Tiwari, A. K., Chakradhar, J. V. U. S., Sethi, M., Pandey, S. N., Rana, R., Tripathi, S., Chourasia, M. K., & Chaurasia, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33623-2.00002-7
Metadata
- Authors
- Gessner, I., & Neundorf, I.
- Affiliations
- University of Cologne (DE)
- Corresponding author
- Neundorf, Ines
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-04-06
- Volume
- 21
- Issue
- 7
- Pages
- 2536
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7177461
- OpenAlex
- W3014732989
- Cited by
- 212
- References
- 115
- Citations by year
- 2026: 26 · 2025: 29 · 2024: 37 · 2023: 40 · 2022: 35 · 2021: 35 · 2020: 9
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Deutsche Forschungsgemeinschaft (NE 1419/10-1)
- European Commission (MSCA-ITN-ETN MAGICBULLET RELOADED 861316)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- cell-penetrating peptides, nanoparticles, surface modification, tumor-homing peptides, targeted drug delivery, cancer diagnosis, cancer therapy, cellular uptake, physicochemical properties, cationic peptides
- MeSH terms
- Theranostic Nanomedicine, Animals, Antineoplastic Agents, Drug Carriers, Humans, Neoplasms, Drug Delivery Systems, Nanoparticles, Chemical Phenomena, Cell-Penetrating Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.